325 7th Street, NW
Washington, DC 20004
Washington, DC 20004
© 2025 PCMA. All Rights Reserved.
STOP THE BIG PHARMA MONEY GRAB: REJECT HOUSE BILL 7192 AND SENATE BILL 11
House Bill 7192 and Senate Bill 11 Would Hike Health Care Costs for Connecticut Families, Employers, and Unions by More Than $301 Million Every Year
House Bill 7192 and Senate Bill 11 are a Big Pharma-backed proposal that would ban pay-for-performance incentives in the private health care marketplace—eliminating a key tool that employers and unions use to lower prescription drug costs for hardworking Connecticut residents.
Instead of lowering the cost of prescription drugs, the bill undermines market-based savings, drives up insurance premiums and increases out-of-pocket costs for over 2 million Connecticut residents who rely on employer or union-provided health coverage.
What House Bill 7192 and Senate Bill 11 Would Do:
Employers and unions negotiate better deals on prescription drugs through voluntarily choosing to hire pharmacy benefit managers (PBMs), critical members of the health care system that pool their negotiating power to unlock savings for health plan sponsors, and the patients and families on these plans.
House Bill 7192 and Senate Bill 11 would ban pay-for-performance incentives in the private health care marketplace that are essential for Connecticut employers and unions to secure significant savings on prescription drugs, directly leading to higher premium costs for patients.
These bills are not about protecting patients—they’re about protecting Big Pharma’s profits.
Connecticut residents can’t afford a bill that increases health care costs while doing nothing to lower prescription drug prices. Contact your legislators today and tell them to reject House Bill 7192 and Senate Bill 11.
